Overcoming Challenges with Pediatric Oral Solid Dose Development
 If you have previously registered, please login here:

Live Webcasts:
Wednesday, October 3, 2012 at 3:00 PM IST (India Standard Time) and 10:00 AM EDT (Eastern Daylight Time)

Pediatric drug products require specialized consideration in formulation development. This niche field has gained attention among regulatory authorities in Europe, North America, and beyond, thereby providing new perspectives on and expectations of pharmaceutical drug formulators. Unique considerations must be addressed when formulating for this population, including excipient selection, dosage form, and patient compliance.

This webinar will provide an overview of current strategies and opportunities in pediatric oral solid dosage formulation development as well as insight into potential delivery options for this niche group. Technical advances and global regulatory expectations will be discussed, as will specifics in multidose and controlled release oral solid dose presentations. Strategies to improve compliance through palatability, inclusion of color for brand recognition, and single daily dose vs. multiple daily dose products will be presented.

Key Learning Objectives
  • Insights into the unique regulatory considerations to be addressed when formulating for the pediatric population
  • Opportunities to improve patient compliance by formulating specifically to meet niche group needs
  • Unique considerations, including excipient selection, dosage form and patient compliance


Angie Drakulich

Editorial Director
Pharmaceutical Technology


Dr. Jenny Walsh

Consultant and Founder Member,
European Pediatric Formulation Initiative
Former Pharmaceutical Development Team Manager,
Astra Zeneca

Kevin Hughes
Formulation Technologies Manager,

This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf, sbarschdorf@advanstar.com.

Register for this FREE Webcast!

Registration is required to attend this event. Please register now.
First Name*
Last Name*
Job Title*
Organization Name*
Organization Address*
Organization Address 2
State or Province*
Zip/Postal Code*
E-mail address*
Work Phone*
Is your company currently developing solid oral dosage forms for pediatrics populations?*
Which platform technologies does your company typically use for pediatric formulations?*
Are Modified Release technologies on your list of formulation choices for pediatrics?*
You must have javascript and cookies enabled to complete registration.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395.

Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Privacy Policy